Yet when free ANGPTL3 and the ANGPTL3/8 complex are assayed separately—as shown in Swedish and other cohorts—the atherogenic lipoprotein profile and coronary heart disease (CHD) risk correlate with the ANGPTL3/8 complex rather than free ANGPTL3 (71). Here, ANGPTL3 is linked to coronary artery disorder.